Global X S&P Biotech ETF (ASX:CURE)

ASX:CURE Holdings Information

ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Madrigal Pharmaceuticals stock at 1.42%, TG Therapeutics at 1.34%, Alkermes at 1.27%, Protagonist Therapeutics at 1.25%, and Insmed at 1.25%.

• Total Holdings: 10
• Top 10 Percentage: 12.60%
• Asset Class: Equity
• ETF Category: Health Care
• Assets: 39.09M
• PE Ratio: n/a

Top 25 Holdings

As of Mar 27, 2026

Filter results

No.	Symbol	Name	% Weight	Shares
1	MDGL	Madrigal Pharmaceuticals, Inc.	1.42%	741
2	TGTX	TG Therapeutics, Inc.	1.34%	11,394
3	ALKS	Alkermes plc	1.27%	11,509
4	PTGX	Protagonist Therapeutics, Inc.	1.25%	3,313
5	INSM	Insmed Incorporated	1.25%	2,293
6	APGE	Apogee Therapeutics, Inc.	1.24%	4,280
7	ARWR	Arrowhead Pharmaceuticals, Inc.	1.23%	5,501
8	SRRK	Scholar Rock Holding Corporation	1.20%	7,402
9	ALNY	Alnylam Pharmaceuticals, Inc.	1.20%	997
10	NBIX	Neurocrine Biosciences, Inc.	1.20%	2,467